Assyro AI

FDA Orange Book · active-ingredient family

Sinecatechins

Sinecatechins is approved in 1 FDA application, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.

Reference-listed drug:VEREGEN · NDA 021902

1

Brand (NDA)

0

Generics (ANDA)

1

Listed patents

0

Exclusivity periods

Brand (NDA) products · ointment

ProductApplicantApplicationTEApproved
VEREGENRLDANI PHARMSNDA 021902—Oct 31, 2006

Listed patents (1)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
7858662Oct 02, 2026in 4 mo
ProductU-172

Sinecatechins — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.

Book a Demo